the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

M’sian bus operator earns RM30k by driving Taylor Swift concertgoers from KL to SG

Taylor Swift’s concert in Singapore for her Eras world tour not only brought joy to thousand of fans but to a particular bus operator from Malaysia.

Bus operator Amirul Sufi shared in a BFM interview that he earned “about RM25,000 to RM30,000” by providing three trips a day to get Swifties from Kuala Lumpur to Singapore.

Amirul explained that after deducting the operating costs, such as gasoline, driver’s salary and maintenance costs, he can earn about RM6,000 in profits per day.

He also emphasised the important of delivering excellent service to ensure customer satisfaction and build loyalty. According to him, the passengers mostly inquire on procedures such as ICA and CIQ at immigration, and their concerns about food and restrooms.

However, its no cake walk for this bus operator as he shared that one of the biggest challenges with this operation is scammers.

“Ticket scammers, hotel scammers, in fact even transport scammers are a thing. We don’t have a huge customer base but we want to build people’s trust and that’s very difficult.”

Admirul admits that although the concert was held in Singapore, it not only benefited the Singapore economy, he also benefited from it.

ALSO READ:

Singapore PM defends exclusive deal to lure Taylor Swift

Singaporean teen, aunt willingly hand Taylor Swift concert tickets to scam victims

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings